JESSIE ALPERIN (M.D.) – Rheumatology Physician, NPI 1447697164
Rheumatology Physician
Main info
Doctor Profile
Profile Insights
NPPES metrics only — not quality of care.
216 RHEUMATOLOGY in MI
Provider Addresses for JESSIE ALPERIN (M.D.)
300 N INGALLS ST STE 7C27
ANN ARBOR, MI 481090400
Phone: (734) 232-1697
Type: Mailing
29992 NORTHWESTERN HWY STE C
FARMINGTON HILLS, MI 483343292
Phone: (248) 851-1423
Fax: (248) 851-5319
Type: Mailing
11885 E 12 MILE RD STE 100B
WARREN, MI 480933465
Phone: (586) 751-7515
Fax: (586) 751-1302
Type: Location
NPPES updates history
No NPPES updates recorded for this provider.
Prescription Activity
Loading prescription activity...
Open Payments (CMS)
CMS reports 48 Open Payments records for all available years, with a total value of $1,088.
Total Amount is formed as General ($1,088) + Research ($0) + Ownership ($0) = $1,088.
Last reported payment date: 2024-12-17 • Largest payer in this snapshot: Amgen Inc. ($387).
Total Amount
$1,088
General + Research + Ownership
Payments
48
Total payment records
General Amount
$1,088
General payments
Research Amount
$0
Research funding
Ownership Amount
$0
Ownership interests
Ownership Count
0
Ownership records
Last Payment Date
2024-12-17
Latest reported date
Top Companies
Largest payers in this snapshot
| Company | Amount |
|---|---|
| Amgen Inc. | $387 |
| Janssen Biotech, Inc. | $344 |
| UCB, Inc. | $101 |
| Novartis Pharmaceuticals Corporation | $57 |
| E.R. Squibb & Sons, L.L.C. | $53 |
Medicare Enrollment & Revalidation
Source: CMS public data · Not endorsed by CMS ·
Educational use only—not medical, billing, or legal advice.
PECOS enrollment status
Participating (accepts Medicare assignment)
Enrollment effective: 2018-05-07
PECOS data refreshed: 2026-05-27
Medicare revalidation (CMS due date list)
Due date not assigned yet
CMS is tracking this Medicare enrollment for revalidation, but has not published a due date.
Enrollment records
1
Earliest due date
Not assigned (TBD)
CMS data updated
2026-06-01
Revalidation progress
- Medicare enrolled
- On CMS revalidation list
- Due date assigned
- Revalidate in PECOS
CMS enrollment records
| Enrollment ID | Type | Specialty | State | Due date |
|---|---|---|---|---|
| I20180507000297 | I | Rheumatology | MI | TBD |
What to do next
- No action required while the due date shows TBD.
- Check the CMS Revalidation Lookup Tool periodically — CMS updates the list about every 60 days.
- Do not submit a revalidation application in PECOS until CMS publishes a concrete due date.
Prepare CMS-855 application → · Look up this NPI in PECOS → · Verify on CMS PECOS
Medicare Utilization (FFS)
Source: CMS public data · Not endorsed by CMS · Beneficiary counts under 11 are suppressed in source data ·
Educational use only—not medical, billing, or legal advice.
Top Medicare procedures (2023) · refreshed 2026-05-27
| HCPCS | Description | Services | Beneficiaries | Medicare allowed |
|---|---|---|---|---|
| J3262 | Injection, tocilizumab, 1 mg | 44,960 | 15 | $0 |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 11,551 | 24 | $0 |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 5,450 | 13 | $0 |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 2,360 | 15 | $0 |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | 462 | 169 | $0 |
Insurance plans in this area (ZIP 48109)
Loading plans...
Group practice members
| Name | Specialty | State |
|---|---|---|
| Cardiovascular Disease (Cardiology) | MI | |
| - | MI | |
| - | MI | |
| - | MI | |
| Internal Medicine | MI | |
| Otolaryngology, Plastic And Reconstructive Surgery | MI | |
| Medical Oncology, Internal Medicine | MI | |
| - | MI | |
| - | AE | |
| Pediatric Medicine | MI |
Reviews
All reviews are moderated before publication. Reviews reflect users' opinions; we do not verify the accuracy of individual reviews.
No reviews yet. Be the first to share your experience — your opinion helps families compare providers.